您的位置: 首页 > 农业专利 > 详情页

Fused [1,2,4]thiadiazine-1,1-dioxide compounds and use thereof in the preparation of medicaments
专利权人:
TAKEDA PHARMACEUTICAL COMPANY LIMITED
发明人:
申请号:
IL22445213
公开号:
IL224452A
申请日:
2013.01.28
申请国别(地区):
IL
年份:
2017
代理人:
摘要:
Provided is a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, which has an AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor potentiating action. The compound of the present invention is useful as a prophylactic or therapeutic drug for depression, schizophrenia, Alzheimers disease or attention deficit hyperactivity disorder (ADHD) and the like.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充